[Clinical evaluation of the antitussive action of libexin and baltix].
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000996:Antitussive Agents / Q000627:therapeutic use*; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003061:Codeine / Q000627:therapeutic use; D003371:Cough / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010069:Oxadiazoles / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use*; D011412:Propanolamines / Q000627:therapeutic use*
D000996:Antitussive Agents; D001559:Benzhydryl Compounds; D010069:Oxadiazoles; D010880:Piperidines; D011412:Propanolamines; C008277:libexin; D003061:Codeine
Klinicheskaia otsenka protivokashlevogo deistviia libeksina i baltiksa